Michael Rohe serves as Vice President of Translational Biomarkers at Evotec since January 2024, overseeing three teams focused on enabling drug discovery through translational biomarkers within neuroscience and other non-CNS conditions. Prior to this role, Michael held positions at Lundbeck as Principal Scientist/Project Leader, specializing in preclinical research across various neurological diseases, and at AbbVie as Laboratory Head, leading in vivo pharmacology research. Experience also includes project management at Proteome Sciences plc, preclinical research at UCB, and basic research as a postdoctoral fellow at the Max Delbrück Center. Michael holds a PhD in Biology from Freie Universität Berlin and a Diploma from Ludwig-Maximilians-Universität München.
This person is not in any teams
This person is not in any offices